Innovator IBD 50 ETF (NYSEARCA:FFTY) Stock Price Down 4.2% – Should You Sell?

Innovator IBD 50 ETF (NYSEARCA:FFTY) fell 4.2% on Monday. The company traded as low as $31.15 and last traded at $31.15. Approximately 57,254 shares changed hands during mid-day trading, an increase of 14% from the average daily volume of 50,187 shares. The stock had previously closed at $32.50.

Innovator IBD 50 ETF Stock Performance

The stock has a fifty day simple moving average of $34.82 and a two-hundred day simple moving average of $37.48. The stock has a market cap of $54.51 million, a PE ratio of 30.34 and a beta of 1.48.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Kraematon Investment Advisors Inc. purchased a new stake in Innovator IBD 50 ETF during the 2nd quarter worth $1,021,000. Guardian Wealth Advisors LLC NC purchased a new position in Innovator IBD 50 ETF in the 2nd quarter valued at about $507,000. Royal Bank of Canada grew its stake in shares of Innovator IBD 50 ETF by 3,222.5% during the first quarter. Royal Bank of Canada now owns 18,274 shares of the company’s stock valued at $611,000 after acquiring an additional 17,724 shares in the last quarter. Concurrent Investment Advisors LLC grew its stake in shares of Innovator IBD 50 ETF by 11.1% during the second quarter. Concurrent Investment Advisors LLC now owns 63,128 shares of the company’s stock valued at $3,349,000 after acquiring an additional 6,321 shares in the last quarter. Finally, Trail Ridge Investment Advisors LLC purchased a new stake in shares of Innovator IBD 50 ETF during the second quarter worth about $210,000.

Innovator IBD 50 ETF Company Profile

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.